Stefano Aliberti, ERS 2018 – Clinical assessment of patients with NTM and its impact on patient care

Stefano Aliberti (University of Milan [UNIMI], Milan, Italy) shares his expert clinical perspectives on the current challenges for diagnosis and treatment of nontuberculous mycobacteria (NTM) infections and how to optimise patient management moving forward.

Questions

Part 1

1. What are the main challenges encountered in nontuberculous mycobacterium (NTM) diagnosis? (0:12)
2. Why are current NTM guidelines poorly adhered to in clinical practice? (2:10)
3. How can use of a multidisciplinary team ensure improved diagnosis and patient management in NTM lung disease? (3:14)

Part 2

1. How does a multidisciplinary team improve patient outcomes in NTM lung disease? (0:12)
2. Are there any particular patient groups for whom management plans are more challenging to establish? (2:14)

Speaker disclosure: Stefano Aliberti has nothing to disclose in relation to this video interview.

Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018, supported by an unrestricted independent educational grant from Insmed.